Subtopic Deep Dive

Primary Hypertrophic Osteoarthropathy
Research Guide

What is Primary Hypertrophic Osteoarthropathy?

Primary hypertrophic osteoarthropathy (PHO) is a rare autosomal recessive genetic disorder characterized by digital clubbing, periostosis, pachydermia, and sometimes myelofibrosis without underlying secondary causes.

PHO, also known as pachydermoperiostosis, features bone and skin changes due to mutations in genes like HPGD and SLCO2A1. Uppal et al. (2008) identified HPGD mutations in 315-cited Nature Genetics paper. Zhang et al. (2011) found SLCO2A1 mutations via exome sequencing in 197-cited American Journal of Human Genetics study.

15
Curated Papers
3
Key Challenges

Why It Matters

PHO genetics research enables precise diagnosis distinguishing it from secondary HOA, as in Yap et al. (2016) imaging features (124 citations). Targeted therapies emerge from prostaglandin pathway defects identified by Uppal et al. (2008) and Diggle et al. (2012, 95 citations). Clinical spectrum delineation by Matucci-Cerinic et al. (1991, 99 citations) improves management of rare skeletal disorders with skin and bone involvement.

Key Research Challenges

Genetic Heterogeneity

PHO arises from mutations in HPGD or SLCO2A1, complicating diagnosis across subtypes. Uppal et al. (2008) linked HPGD to complete PHO, while Zhang et al. (2011) associated SLCO2A1 with incomplete forms. Identifying rare variants requires advanced sequencing.

Pathophysiology Mechanisms

Prostaglandin accumulation drives periostosis and pachydermia, but fibrosis links remain unclear. Diggle et al. (2012) reported myelofibrosis in SLCO2A1 cases. Telocyte loss in related fibrosis noted by Manetti et al. (2014, 102 citations) suggests stromal cell roles.

Phenotypic Variability

PHO spectrum includes pachydermoperiostosis variants with variable severity. Vogl and Goldfischer (1962, 127 citations) defined classic features; Matucci-Cerinic et al. (1991) outlined clinical range. Genotype-phenotype correlations challenge prognosis.

Essential Papers

1.

Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy

Sandeep Uppal, Christine P. Diggle, Ian Carr et al. · 2008 · Nature Genetics · 315 citations

2.

Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic Osteoarthropathy

Zhenlin Zhang, Weibo Xia, Jin‐Wei He et al. · 2011 · The American Journal of Human Genetics · 197 citations

3.

Paraneoplastic syndromes in rheumatology

Bernhard Manger, Georg Schett · 2014 · Nature Reviews Rheumatology · 146 citations

4.

A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter

Junji Umeno, Tadakazu Hisamatsu, Motohiro Esaki et al. · 2015 · PLoS Genetics · 141 citations

Previously, we proposed a rare autosomal recessive inherited enteropathy characterized by persistent blood and protein loss from the small intestine as chronic nonspecific multiple ulcers of the sm...

5.

Pachydermoperiostosis

Alfred Vogl, Sidney Goldfischer · 1962 · The American Journal of Medicine · 127 citations

6.

Hypertrophic Osteoarthropathy: Clinical and Imaging Features

Felix Y. Yap, Matt Skalski, Dakshesh B. Patel et al. · 2016 · Radiographics · 124 citations

Hypertrophic osteoarthropathy (HOA) is a medical condition characterized by abnormal proliferation of skin and periosteal tissues involving the extremities and characterized by three clinical featu...

7.

A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis

Mirko Manetti, Irene Rosa, Luca Messerini et al. · 2014 · Journal of Cellular and Molecular Medicine · 102 citations

Abstract Systemic sclerosis ( SS c) is a complex connective tissue disease characterized by fibrosis of the skin and various internal organs. In SS c, telocytes, a peculiar type of stromal (interst...

Reading Guide

Foundational Papers

Start with Uppal et al. (2008) for HPGD discovery and Zhang et al. (2011) for SLCO2A1 exome findings, as they establish genetic basis with 315 and 197 citations. Vogl and Goldfischer (1962) provides classic pachydermoperiostosis description.

Recent Advances

Study Diggle et al. (2012) for myelofibrosis links and Yap et al. (2016) for imaging advances. Umeno et al. (2015, 141 citations) extends SLCO2A1 to enteropathy.

Core Methods

Exome sequencing (Zhang et al., 2011), prostaglandin dehydrogenase assays (Uppal et al., 2008), radiographic periostosis evaluation (Yap et al., 2016).

How PapersFlow Helps You Research Primary Hypertrophic Osteoarthropathy

Discover & Search

Research Agent uses searchPapers and exaSearch to find PHO genetics papers like 'Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy' by Uppal et al. (2008). citationGraph reveals connections between HPGD/SLCO2A1 studies; findSimilarPapers expands to related prostaglandin transporter works.

Analyze & Verify

Analysis Agent applies readPaperContent to extract mutation data from Zhang et al. (2011), then verifyResponse with CoVe checks claims against abstracts. runPythonAnalysis parses citation networks or simulates prostaglandin levels using pandas; GRADE grading scores evidence strength for HPGD vs SLCO2A1 causality.

Synthesize & Write

Synthesis Agent detects gaps in myelofibrosis therapies from Diggle et al. (2012), flags contradictions in phenotypic spectra. Writing Agent uses latexEditText for case reports, latexSyncCitations for Uppal et al. references, latexCompile for full reviews, exportMermaid for gene mutation diagrams.

Use Cases

"Extract SLCO2A1 mutations from PHO exome studies and plot variant frequencies"

Research Agent → searchPapers('SLCO2A1 PHO') → Analysis Agent → readPaperContent(Zhang 2011) → runPythonAnalysis(pandas variant tally, matplotlib plot) → researcher gets CSV of mutations with frequency bar chart.

"Draft LaTeX review comparing HPGD and SLCO2A1 PHO subtypes"

Research Agent → citationGraph(Uppal 2008) → Synthesis → gap detection → Writing Agent → latexEditText(structure sections) → latexSyncCitations → latexCompile → researcher gets compiled PDF with cited figures.

"Find GitHub repos implementing PHO genetic analysis code"

Research Agent → searchPapers('PHO genetics') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets annotated repo list with SLCO2A1 variant callers.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ HOA papers, chaining searchPapers → citationGraph → GRADE grading for PHO genetics hierarchy. DeepScan applies 7-step analysis with CoVe checkpoints to verify Uppal et al. (2008) mutation impacts. Theorizer generates hypotheses on SLCO2A1-prostaglandin links from Diggle et al. (2012).

Frequently Asked Questions

What defines primary hypertrophic osteoarthropathy?

PHO is genetic HOA with clubbing, periostosis, pachydermia absent secondary causes like cancer (Martínez-Lavín et al., 1988). Also called pachydermoperiostosis (Vogl and Goldfischer, 1962).

What are main methods for PHO diagnosis?

Genetic sequencing targets HPGD/SLCO2A1 mutations (Uppal et al., 2008; Zhang et al., 2011). Imaging shows periosteal reaction (Yap et al., 2016). Clinical spectrum assessment per Matucci-Cerinic et al. (1991).

What are key papers on PHO genetics?

Uppal et al. (2008, 315 citations) found HPGD mutations. Zhang et al. (2011, 197 citations) identified SLCO2A1 via exome sequencing. Diggle et al. (2012, 95 citations) linked to myelofibrosis.

What open problems exist in PHO research?

Unclear genotype-phenotype links and therapy targets for fibrosis. Rare variants need larger cohorts. Prostaglandin pathway modulators untested clinically.

Research Hypertrophic osteoarthropathy and related conditions with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Primary Hypertrophic Osteoarthropathy with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers